CWM
NVS icon

Confluence Wealth Management’s Novartis NVS Stock Holding History

Confluence Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,938
Closed -$238K – 105
2014
Q2 		$238K Buy
+2,938
New +$231K 0.14% 122

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Confluence Wealth Management's NVS Position: Q3 2014 in Review

Confluence Wealth Management sold out of Novartis (NVS) in Q3 2014, closing a stake of 2,938 shares — an estimated $238K sold.

Confluence Wealth Management first reported a position in NVS in Q2 2014 and held it in 1 quarter. The position peaked at $238K in Q2 2014. 874 funds tracked by Wall St. Rank hold NVS as of Q3 2014.

  • Confluence Wealth Management reported no remaining Novartis position as of Q3 2014 after selling out during the quarter.
  • Confluence Wealth Management sold 2,938 Novartis shares in Q3 2014, an estimated $238K.
  • Confluence Wealth Management first reported a position in Novartis in Q2 2014 and held it in 1 quarter.
  • Confluence Wealth Management's Novartis position peaked at $238K in Q2 2014.
  • 874 funds tracked by Wall St. Rank held Novartis as of Q3 2014.

Based on Confluence Wealth Management's 13F filing for Q3 2014, filed 14 Nov 2014.